We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




High HbA1c Levels Do Not Always Lead to Diabetes

By LabMedica International staff writers
Posted on 25 Jul 2019
Prediabetes is an asymptomatic condition preceding type 2 diabetes. More...
It is characterized by hyperglycemia, which is defined as a blood glucose level that is higher than normal but below the level for a clinical diagnosis of diabetes.

Glycated hemoglobin (HbA1c) values increase with age amongst diabetes‐free subjects, and low glucose level may increase mortality in old age. Questions remain on which factors are related to the reversion from prediabetes to normoglycemia, independently of mortality amongst the older population.

Scientists at the Karolinska Institute (Stockholm, Sweden) followed 2,575 men and women aged 60 and older without diabetes for up to 12 years. At the start of the study, 918 people, or 36% of the group, did have higher-than-normal blood sugar levels that were still below the threshold for diabetes.

HbA1c was collected at regular interval and until December 2010, HbA1c was assessed with Swedish Mono‐S filament High Performance Liquid Chromatography, and 1.1% was added to the individual's values to render them equal to international values in accordance with National Glycohemoglobin Standardization Program (NGSP; HbA1c in %). Since 1 January 2011, HbA1c has been assessed with the International Federation of Clinical Chemistry (IFCC) reference method. A standard equation (NGSP = [0.9148 * IFCC] + 2.152) was applied to convert IFCC HbA1c (in mmol mol−1) to NGSP value (in %), to render HbA1c results from all waves comparable.

The scientists reported that only 119 people, 13% of those who started out with elevated blood sugar, went on to develop diabetes. Another 204, or 22%, had blood sugar levels drop enough to no longer be considered prediabetic. Obese adults with prediabetes were more likely to progress to full-blown diabetes. Ying Shang, MMSc, of the Aging Research Center at the Karolinska Institute and first author of the study, said, “Progressing to diabetes is not the only destination. In fact, the chance to stay prediabetic or even revert back to (normal blood sugar) is actually pretty high (64%), without taking medication. Lifestyle changes such as weight management or blood pressure control may help stop prediabetes from progressing.” The study was published on June 4, 2019, in the Journal of Internal Medicine.

Related Links:
Karolinska Institute


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.